Rift Valley fever: an uninvited zoonosis in the Arabian peninsula

scientific article

Rift Valley fever: an uninvited zoonosis in the Arabian peninsula is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0924-8579(02)00295-9
P698PubMed publication ID12615379

P50authorZiad A MemishQ76089502
P2093author name stringHanan H Balkhy
P2860cites workComparative efficacy of insect repellents against mosquito bitesQ28208947
Viral hemorrhagic fever hazards for travelers in AfricaQ34398543
An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.Q37320063
Climate-disease connections: Rift Valley Fever in Kenya.Q38456912
Recurrence of Rift Valley fever in EgyptQ38880763
The Rift Valley fever epizootic in Egypt 1977–1978 2. Ecological and entomological studiesQ39076413
Rift Valley fever, Egypt 1977: disease spread by windborne insect vectors?Q39445205
Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compoundsQ39467349
Rift Valley fever virus ecology and the epidemiology of disease emergenceQ40581805
First isolation of the Rift Valley fever virus from Culex poicilipes (Diptera: Culicidae) in natureQ40604475
Immunogenicity of an inactivated Rift Valley fever vaccine in humans: a 12-year experience.Q40632227
Rift valley fever surveillance in the lower Senegal river basin: update 10 years after the epidemicQ40632284
Rift Valley fever in Nigeria: infections in humans.Q40663886
Rift Valley fever in rural northern Senegal: human risk factors and potential vectors.Q40700580
Repelling mosquitoesQ44148320
Spread of Rift Valley fever virus from continental AfricaQ45894467
P433issue2
P921main subjectzoonosisQ182672
Rift Valley feverQ326638
Rift Valley fever phlebovirusQ24809101
P304page(s)153-157
P577publication date2003-02-01
P1433published inInternational Journal of Antimicrobial AgentsQ15724616
P1476titleRift Valley fever: an uninvited zoonosis in the Arabian peninsula
P478volume21

Reverse relations

cites work (P2860)
Q42218824A One Health approach to the control of zoonotic vectorborne pathogens
Q28647232A Spatial Analysis of Rift Valley Fever Virus Seropositivity in Domestic Ruminants in Tanzania
Q40379142A complex adenovirus-vectored vaccine against Rift Valley fever virus protects mice against lethal infection in the presence of preexisting vector immunity
Q43046864A glycerophospholipid-specific pocket in the RVFV class II fusion protein drives target membrane insertion.
Q40197590A modeling approach to investigate epizootic outbreaks and enzootic maintenance of Rift Valley fever virus
Q37561593A need for One Health approach - lessons learned from outbreaks of Rift Valley fever in Saudi Arabia and Sudan
Q98465932A protective bivalent vaccine against Rift Valley fever and bluetongue
Q58757705A quantitative exploration of nomadic pastoralists' knowledge and practices towards Rift Valley fever in Niger State, North-central Nigeria: The associated socio-cultural drivers
Q33621078A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challenge
Q34487937A systematic review of Rift Valley Fever epidemiology 1931-2014.
Q36414218Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein
Q64114488An Overview of the Most Significant Zoonotic Viral Pathogens Transmitted from Animal to Human in Saudi Arabia
Q40043424An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep
Q24701804Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis
Q35778817Arboviral encephalitides: transmission, emergence, and pathogenesis
Q35083136Assessment of research productivity of Arab countries in the field of infectious diseases using Web of Science database
Q38613824Bunyaviruses and the type I interferon system
Q37087027Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs
Q38328619Characterization of RNA aptamers directed against the nucleocapsid protein of Rift Valley fever virus.
Q40448667Characterization of Rift Valley fever virus transcriptional terminations.
Q47159695Climate change and water management in the biblical city of Dan.
Q33796551Comparative production analysis of three phlebovirus nucleoproteins under denaturing or non-denaturing conditions for crystallographic studies
Q35797105Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines
Q33705717Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs
Q26315243Detection of Sindbis and Inkoo Virus RNA in Genetically Typed Mosquito Larvae Sampled in Northern Sweden
Q35126733Development of a novel, single-cycle replicable rift valley Fever vaccine
Q40123495Development of a sheep challenge model for Rift Valley fever.
Q36559849Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells
Q35107614Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR.
Q34770212Ecological niche modeling and land cover risk areas for rift valley fever vector, culex tritaeniorhynchus giles in Jazan, Saudi Arabia.
Q50329180Efficacy of different DNA and MVA prime-boost vaccination regimens against a Rift Valley fever virus (RVFV) challenge in sheep 12 weeks following vaccination
Q39893246Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses
Q40397884Electron cryo-microscopy and single-particle averaging of Rift Valley fever virus: evidence for GN-GC glycoprotein heterodimers
Q33845578Emergence of zoonotic arboviruses by animal trade and migration
Q89967836Emerging Threats to Animals in the United Kingdom by Arthropod-Borne Diseases
Q35869028Emerging infections in animals--potential new zoonoses?
Q36312952Emerging infectious diseases: the Bunyaviridae
Q56561007Environmental limits of Rift Valley fever revealed using ecoepidemiological mechanistic models
Q34034096Epidemiologic and Clinical Aspects of a Rift Valley Fever Outbreak in Humans in Tanzania, 2007
Q40200902Epidemiological study of Rift Valley fever virus in Kigoma, Tanzania
Q36300604Ethnic groups' knowledge, attitude and practices and Rift Valley fever exposure in Isiolo County of Kenya
Q54251506Evaluation of Fluorescence Microsphere Immunoassay for the Detection of Antibodies to Rift Valley Fever Nucleocapsid Protein and Glycoproteins.
Q35840989First External Quality Assessment of Molecular and Serological Detection of Rift Valley Fever in the Western Mediterranean Region
Q38778411Generation of a Single-Cycle Replicable Rift Valley Fever Vaccine
Q26314582Has Rift Valley fever virus evolved with increasing severity in human populations in East Africa?
Q30230718Health risks at the Hajj
Q21144476High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses
Q91728993High seroconversion rate to Rift Valley fever virus in cattle and goats in far northern KwaZulu-Natal, South Africa, in the absence of reported outbreaks
Q35363438High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses
Q92081517Identification and evaluation of antivirals for Rift Valley fever virus
Q36462318Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay
Q39197757Identification of suitable areas for the occurrence of Rift Valley fever outbreaks in Spain using a multiple criteria decision framework
Q33429285Inflammatory Biomarkers Associated with Lethal Rift Valley Fever Encephalitis in the Lewis Rat Model
Q38677880Inter-epidemic Rift Valley fever virus seroconversions in an irrigation scheme in Bura, south-east Kenya
Q37420463Inter-epidemic and between-season persistence of rift valley fever: vertical transmission or cryptic cycling?
Q34952316Inter-epidemic transmission of Rift Valley fever in livestock in the Kilombero River Valley, Tanzania: a cross-sectional survey
Q42928719Larvicidal Activities of Indigenous Bacillus thuringiensis Isolates and Nematode Symbiotic Bacterial Toxins against the Mosquito Vector, Culex pipiens (Diptera: Culicidae).
Q35892951Lay perceptions of risk factors for Rift Valley fever in a pastoral community in northeastern Kenya
Q42177525Mapping of major diseases and devising prevention and control regimen to common diseases in cattle and shoats in Dassenech district of South Omo Zone, South-Western Ethiopia
Q34490520Mechanism of tripartite RNA genome packaging in Rift Valley fever virus
Q30421040Modelling the effects of seasonality and socioeconomic impact on the transmission of rift valley Fever virus
Q34660072Modelling vertical transmission in vector-borne diseases with applications to Rift Valley fever
Q57017486Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~!
Q33886954Molecular biology of rift valley Fever virus
Q36291844Mosquito vectors survey in the AL-Ahsaa district of eastern Saudi Arabia
Q40083734Mouse model for the Rift Valley fever virus MP12 strain infection.
Q35024013NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture.
Q36315241NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis
Q89996262NSs Filament Formation Is Important but Not Sufficient for RVFV Virulence In Vivo
Q39195523NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase
Q47144027Opinion of the Scientific Panel on Animal Health and Welfare (AHAW) on a request from the Commission related to “The Risk of a Rift Valley Fever Incursion and its Persistence within the Community”
Q37567073Out of the bush: the Asian bush mosquito Aedes japonicus japonicus (Theobald, 1901) (Diptera, Culicidae) becomes invasive
Q43167772Overlapping CD8+ and CD4+ T-cell epitopes identification for the progression of epitope-based peptide vaccine from nucleocapsid and glycoprotein of emerging Rift Valley fever virus using immunoinformatics approach.
Q90695793Patterns of Rift Valley fever virus seropositivity in domestic ruminants in central South Africa four years after a large outbreak
Q28469517Phylogeography of Rift Valley Fever Virus in Africa and the Arabian Peninsula
Q28742390Planning for Rift Valley fever virus: use of geographical information systems to estimate the human health threat of white-tailed deer (Odocoileus virginianus)-related transmission
Q34633660Population genetics of two key mosquito vectors of Rift Valley Fever virus reveals new insights into the changing disease outbreak patterns in Kenya
Q36053652Potential effects of Rift Valley fever in the United States
Q40346522Potential for North American Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus
Q40140711Potential for Psorophora columbiae and Psorophora ciliata Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus
Q30382776Public health. Pandemic H1N1 and the 2009 Hajj.
Q35066405Public, environmental, and occupational health research activity in Arab countries: bibliometric, citation, and collaboration analysis
Q60959433RVFV Infection in Goats by Different Routes of Inoculation
Q27491320Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA
Q34292066Recent outbreaks of rift valley Fever in East Africa and the middle East
Q37513461Reemergence of Rift Valley fever, Mauritania, 2010.
Q33570326Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines
Q33745109Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells
Q35975309Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths
Q27488329Rift Valley Fever, Mayotte, 2007–2008
Q41922817Rift Valley Fever: Does Wildlife Play a Role?
Q42599665Rift Valley fever in goats, Cameroon
Q40038707Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments
Q39251803Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
Q26315215Rift Valley fever vector diversity and impact of meteorological and environmental factors on Culex pipiens dynamics in the Okavango Delta, Botswana
Q40499504Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment
Q36397378Rift Valley fever virus strain MP-12 enters mammalian host cells via caveola-mediated endocytosis
Q36797004Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.
Q33960690Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention
Q56917525Rift Valley fever: current challenges and future prospects
Q33755025Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system
Q34174444Rift valley fever: recent insights into pathogenesis and prevention
Q64288229Risk factors associated with sustained circulation of six zoonotic arboviruses: a systematic review for selection of surveillance sites in non-endemic areas
Q28066283Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study
Q40322035Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves
Q36085506Safety and immunogenecity of a live attenuated Rift Valley fever vaccine (CL13T) in camels
Q64246621Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania
Q91656354Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves
Q40075001Serological and genomic evidence of Rift Valley fever virus during inter-epidemic periods in Mauritania
Q40153798Serological surveillance studies confirm the Rift Valley fever virus free status in South Korea
Q29543293Seroprevalence of Alkhurma and Other Hemorrhagic Fever Viruses, Saudi Arabia
Q57806005Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo
Q36337127Seroprevalence of Rift Valley fever virus in livestock during inter-epidemic period in Egypt, 2014/15.
Q37067311Seroprevalence of Rift Valley fever virus in sheep and goats in Zambézia, Mozambique
Q37433779Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells
Q27488344Single-particle cryo-electron microscopy of Rift Valley fever virus
Q37300854Socio-economic impact of Rift Valley fever to pastoralists and agro pastoralists in Arusha, Manyara and Morogoro regions in Tanzania
Q27468611Spatial Heterogeneity of Habitat Suitability for Rift Valley Fever Occurrence in Tanzania: An Ecological Niche Modelling Approach
Q35106416Spatial and temporal pattern of Rift Valley fever outbreaks in Tanzania; 1930 to 2007.
Q30855605Spatial, seasonal and climatic predictive models of Rift Valley fever disease across Africa.
Q38615473Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope
Q27026883The 2007 Rift Valley fever outbreak in Sudan
Q36506825The C-terminal region of Rift Valley fever virus NSm protein targets the protein to the mitochondrial outer membrane and exerts antiapoptotic function
Q40174551The genetic basis for susceptibility to Rift Valley fever disease in MBT/Pas mice
Q27311874The hexamer structure of Rift Valley fever virus nucleoprotein suggests a mechanism for its assembly into ribonucleoprotein complexes
Q63246310The influence of raw milk exposures on Rift Valley fever virus transmission
Q37433782The risk of Rift Valley fever virus introduction and establishment in the United States and European Union
Q33195339Tropical dermatology: viral tropical diseases
Q28079654Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses
Q34059387Uukuniemi Phlebovirus assembly and secretion leave a functional imprint on the virion glycome
Q40399200Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus
Q30234919Viral hemorrhagic fevers in the Tihamah region of the western Arabian Peninsula
Q30389357Zoonoses in the Arabian Peninsula
Q30987421Zoonotic risks from small ruminants

Search more.